Skip to main content
Clinical Trials/EUCTR2007-007518-13-SI
EUCTR2007-007518-13-SIActive, not recruitingNot Applicable

THE EFFECTS OF LEVOSIMENDAN ON ARTERIALL STIFFNESS IN PATIENTS WITH ADVANCED CHRONIC HEART FAILURE

niversity Medical Centre Ljubljana0 sitesStarted: December 19, 2007Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Age above 18 years
  • 2. At least a 3-month history of advanced heart failure symptoms (NYHA III)
  • 3. Evidence of impaired left ventricular ejection fraction (EF<40%) on echocardiography and/or contrast ventriculography
  • 4. Serum creatinine below 350 µmol/l
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • 1. Advanced Renal insuficiency (Creatinine clearance of less than 30 ml/min)
  • 2. Advanced liver failure (liver enzymes > 5x ULN)
  • 3. Hipotension (systolic blood pressure < 100 mmHg)
  • 4. Tachycardia (heart rate >100/min)

Investigators

Sponsor
niversity Medical Centre Ljubljana

Similar Trials

THE EFFECTS OF LEVOSIMENDAN ON ARTERIALL... | Clinical Trial